{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:23:24Z","timestamp":1791685404239,"version":"4.3.4"},"reference-count":279,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":177,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.addr.2020.06.025","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T11:14:48Z","timestamp":1593256488000},"page":"65-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":393,"special_numbering":"C","title":["Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies"],"prefix":"10.1016","volume":"163-164","author":[{"given":"Frederik","family":"Soetaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi","family":"Korangath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Serantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Fiering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ivkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2020.06.025_bb0005","first-page":"22","article-title":"There\u2019s plenty of room at the bottom","volume":"23","author":"Feynman","year":"1960","journal-title":"Eng. Sci."},{"key":"10.1016\/j.addr.2020.06.025_bb0010","author":"NNI"},{"key":"10.1016\/j.addr.2020.06.025_bb0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tibtech.2011.03.001","article-title":"Cancer theranostics: the rise of targeted magnetic nanoparticles","volume":"29","author":"Cole","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.addr.2020.06.025_bb0020","series-title":"Commercialization Consideration, in: Nanobiotechnology in Food: Concepts, Applications and Perspectives","first-page":"137","author":"Jafarizadeh-Malmiri","year":"2019"},{"key":"10.1016\/j.addr.2020.06.025_bb0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/wnan.28","article-title":"Commercialization of nanotechnology","volume":"1","author":"Hobson","year":"2009","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2020.06.025_bb0030","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s40265-015-0453-3","article-title":"Anticancer drug delivery: an update on clinically applied nanotherapeutics","volume":"75","author":"Marchal","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2020.06.025_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17425247.2017.1262346","article-title":"Cancer nanomedicines: oversold or underappreciated?","volume":"14","author":"van der Meel","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2020.06.025_bb0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41467-017-00600-w","article-title":"Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2020.06.025_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.addr.2020.06.025_bb0050","unstructured":"P. Korangath, J.D. Barnett, A. Sharma, E.T. Henderson, J. Stewart, S-H. Yu, S.K. Kandala, C-T. Yang, M. Hedayati, T. Armstrong, E. Jaffee, C. Gruettner, X.C. Zhou, W. Fu, C. Hu, S. Sukumar, B.W. Simons, R. Ivkov, Nanoparticle interactions with immune cells dominate tumor retention and induce T-cell mediated tumor suppression in breast cancer. Sci. Adv., (in press)."},{"key":"10.1016\/j.addr.2020.06.025_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.taap.2015.12.022","article-title":"Current understanding between nanoparticles and the immune system","volume":"299","author":"Dobrovolskaia","year":"2015","journal-title":"Toxicol. App. Pharmacol."},{"key":"10.1016\/j.addr.2020.06.025_bb0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/wnan.1274","article-title":"Stimulating antitumor immunity with nanoparticles","volume":"6","author":"Sheen","year":"2014","journal-title":"Wires Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2020.06.025_bb0065","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/asheducation-2010.1.338","article-title":"Clinical use of intravenous iron: administration, efficacy, and safety","volume":"2010","author":"Auerbach","year":"2010","journal-title":"Hematology-Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.addr.2020.06.025_bb0070","first-page":"2313","article-title":"Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies","volume":"25","author":"Lebrun","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.addr.2020.06.025_bb0075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0304-8853(99)00088-8","article-title":"Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles","volume":"201","author":"Jordan","year":"1999","journal-title":"J. Mag. Magn. Mat."},{"key":"10.1016\/j.addr.2020.06.025_bb0080","article-title":"Fundamentals and advances in magnetic hyperthermia","volume":"2","author":"P\u00e9drigo","year":"2015","journal-title":"Appl. Phys. Rev."},{"key":"10.1016\/j.addr.2020.06.025_bb0085","doi-asserted-by":"crossref","first-page":"101282","DOI":"10.1016\/j.jddst.2019.101282","article-title":"Preclinical evaluation and clinical translation of magnetite-based nanomedicines","volume":"54","author":"Nuzhina","year":"2019","journal-title":"J. Drug Del. Sci. Tech."},{"key":"10.1016\/j.addr.2020.06.025_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2020.06.025_bb0095","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2020.06.025_bb0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ccr.2018.12.015","article-title":"Nanomaterial-induced ferroptosis for cancer specific therapy","volume":"382","author":"Liu","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.addr.2020.06.025_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-018-03005-x","article-title":"Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients","volume":"141","author":"Grauer","year":"2019","journal-title":"J. Neuro-Onc."},{"key":"10.1016\/j.addr.2020.06.025_bb0110","series-title":"Guidance for Industry: Considering whether an FDA-regulated produce involves the application of nanotechnology","author":"Office of the Commissioner","year":"2014"},{"key":"10.1016\/j.addr.2020.06.025_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40005-017-0370-4","article-title":"Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics","volume":"48","author":"Choi","year":"2018","journal-title":"J. Pharmac. Invest."},{"key":"10.1016\/j.addr.2020.06.025_bb0120","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/coatings9100628","article-title":"Benefits of nanomedicine for therapeutic intervention in malignant diseases","volume":"9","author":"Sevastre","year":"2019","journal-title":"Coatings"},{"key":"10.1016\/j.addr.2020.06.025_bb0125","series-title":"Chemistry, manufacturing, and controls changes to an approved application: Certain biological products (Draft Guidance for Industry), 21CFR 32(e)","author":"US Department of Health and Human Services, Food and Drug Administration","year":"2017"},{"key":"10.1016\/j.addr.2020.06.025_bb0130","unstructured":"FYs 2013-2017 regulatory science report Complex Mixtures and Peptides. Report by US Food and Drug Administration, US Department of Health and Human Services(https:\/\/www.fda.gov\/media\/112368\/download)."},{"key":"10.1016\/j.addr.2020.06.025_bb0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/acsnano.7b05108","article-title":"Nanotechnology strategies to advance outcomes in clinical cancer care","volume":"12","author":"Harshorn","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.06.025_bb0140","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.06.025_bb0145","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acsnano.9b04266","article-title":"Integrating nanotechnology into cancer care","volume":"13","author":"Grodzinski","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.06.025_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin. Trans. Med."},{"key":"10.1016\/j.addr.2020.06.025_bb0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy","volume":"200","author":"Wicki","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.06.025_bb0160","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotech."},{"key":"10.1016\/j.addr.2020.06.025_bb0165","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMra0912273","article-title":"Nanomedicine: current concepts","volume":"363","author":"Kim","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2020.06.025_bb0170","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2020.06.025_bb0175","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2008.11.010","article-title":"Polymeric drugs for efficient tumor targeted drug delivery based on EPR-effect","volume":"71","author":"Maeda","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2020.06.025_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.addr.2020.06.025_bb0185","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/mp200394t","article-title":"Nanomedicine(s) under the microscope","volume":"8","author":"Duncan","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2020.06.025_bb0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug. Del. Rev."},{"key":"10.1016\/j.addr.2020.06.025_bb0195","doi-asserted-by":"crossref","first-page":"7087s","DOI":"10.1158\/1078-0432.CCR-1004-0022","article-title":"Development of tumor targeting bioprobes (111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy","volume":"11","author":"DeNardo","year":"2005","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.addr.2020.06.025_bb0200","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/bc800015n","article-title":"NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics","volume":"19","author":"Natarajan","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2020.06.025_bb0205","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamaoncol.2018.2168","article-title":"Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: a phase 2 clinical trial","volume":"4","author":"Autio","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.addr.2020.06.025_bb0210","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12885-016-2385-z","article-title":"HERMIONE: a randomized phase 2 trial of MM-302 plus Trastuzumab versus chemotherapy of Physician\u2019s choice plus Trastuzumab in patients with previously treated, anthracycline naive, HER2-positive, locally advanced\/metastatic breast cancer","volume":"16","author":"Miller","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.addr.2020.06.025_bb0215","first-page":"437","article-title":"Thermal dosimetry predictive of efficacy of 111In-Ch L6 nanoparticle AMF induced therapy for human breast cancer in mice","volume":"48","author":"DeNardo","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2020.06.025_bb0220","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1389-1723(03)90138-1","article-title":"Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles","volume":"96","author":"Ito","year":"2003","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.addr.2020.06.025_bb0225","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3109\/02656736.2013.837200","article-title":"Magnetic fluid hyperthermia: advances, challenges, and opportunity","volume":"29","author":"Kozissnik","year":"2013","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0230","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/mp400703d","article-title":"Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation","volume":"11","author":"Yang","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2020.06.025_bb0235","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae - the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.06.025_bb0240","first-page":"670","article-title":"The anthracyclines: will we ever find a better doxorubicin?","volume":"19","author":"Weiss","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.addr.2020.06.025_bb0245","series-title":"Handbook of Cancer Chemotherapy","author":"Skeel","year":"1999"},{"key":"10.1016\/j.addr.2020.06.025_bb0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.addr.2020.06.025_bb0255","series-title":"Chemotherapy and Cardiac Toxicity \u2014 The Lesser of Two Evils","author":"Kenyon","year":"2010"},{"key":"10.1016\/j.addr.2020.06.025_bb0260","series-title":"Cancer Management: a Multidisciplinary Approach","article-title":"Principles of oncologic pharmacotherapy","author":"Takimoto","year":"2008"},{"key":"10.1016\/j.addr.2020.06.025_bb0265","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3109\/08982109509012690","article-title":"Rational design of amphiphile-based drug carriers and sterically stabilized carriers","volume":"5","author":"Barenholz","year":"1995","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.addr.2020.06.025_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/LPR-120017482","article-title":"Relevancy of drug loading to liposomal formulation therapeutic efficacy","volume":"13","author":"Barenholz","year":"2003","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.addr.2020.06.025_bb0275","series-title":"Stealth Liposomes","year":"1995"},{"key":"10.1016\/j.addr.2020.06.025_bb0280","first-page":"987","article-title":"Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes","volume":"54","author":"Gabizon","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2020.06.025_bb0285","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2020.06.025_bb0290","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.0.CO;2-1","article-title":"Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes","volume":"86","author":"Symon","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.addr.2020.06.025_bb0295","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0005-2736(89)90329-5","article-title":"Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetic studies","volume":"980","author":"Druckmann","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2020.06.025_bb0300","first-page":"3645","article-title":"Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?","volume":"5","author":"Hong","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2020.06.025_bb0305","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.nano.2016.05.019","article-title":"Gulp1 is associated with the pharmacokinitecs of PEGylated liposomal doxorubicin (PLD) in inbred mouse strains","volume":"12","author":"Song","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2020.06.025_bb0310","series-title":"Nanomedicine review: Clinical developments in liposomal applications","volume":"10","author":"Beltr\u00e1n-Gracia","year":"2019"},{"key":"10.1016\/j.addr.2020.06.025_bb0315","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2016.04.028","article-title":"Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin","volume":"22","author":"Petersen","year":"2016","journal-title":"J. Control. Drug Release"},{"key":"10.1016\/j.addr.2020.06.025_bb0320","unstructured":"Doxil\u00ae, product insert."},{"key":"10.1016\/j.addr.2020.06.025_bb0325","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ajh.21154","article-title":"Intravenous iron: from anathema to standard of care","volume":"83","author":"Auerbach","year":"2008","journal-title":"Am. J. Hematol."},{"issue":"Suppl. 5","key":"10.1016\/j.addr.2020.06.025_bb0330","first-page":"S93","article-title":"Structure, chemistry, and pharmacokinetics of intravenous iron agents","volume":"15","author":"B.G. Danielson BG.","year":"2004","journal-title":"J. Am. Soc. Nephrolo"},{"key":"10.1016\/j.addr.2020.06.025_bb0335","unstructured":"Search conducted on DailyMed, US National Library of Medicine, NIH (https:\/\/dailymed.nlm.nih.gov\/dailymed\/). Search terms: \u2018iron\u2019 (active ingredient) AND \u2018injection\u2019 (dosage and administration) AND \u2018anemia\u2019 (indications and usage) OR \u2018iron deficiency\u2019 (indications and usage) performed 2020-02-03."},{"key":"10.1016\/j.addr.2020.06.025_bb0340","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/ph11030082","article-title":"Intravenous irons: from basic science to clinical practice","volume":"11","author":"Bhandari","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.addr.2020.06.025_bb0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/asheducation-2016.1.57","article-title":"Single-dose intravenous iron for iron deficiency: a new paradigm","volume":"2016","author":"Auerbach","year":"2016","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.addr.2020.06.025_bb0350","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fonc.2018.00549","article-title":"Iron in the tumor microenvironment \u2013 connecting the dots","volume":"549","author":"Pfeifhofer-Obermair","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.addr.2020.06.025_bb0355","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.addr.2020.06.025_bb0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1778-428X.2007.00050.x","article-title":"Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations","volume":"9","author":"Moneim","year":"2007","journal-title":"Transfus. Alternat. Transfus. Med."},{"key":"10.1016\/j.addr.2020.06.025_bb0365","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1471-0528.1964.tb04380.x","article-title":"Treatment of 300 cases of iron deficiency of pregnancy by total dose infusion of iron-dextran complex","volume":"71","author":"Varde","year":"1964","journal-title":"J Obstet Gynaecol Br Comm."},{"key":"10.1016\/j.addr.2020.06.025_bb0370","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/08860220701278208","article-title":"Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?","volume":"29","author":"Sav","year":"2007","journal-title":"Ren. Fail."},{"key":"10.1016\/j.addr.2020.06.025_bb0375","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/en.2009-1082","article-title":"Nanoparticles and the immune system","volume":"151","author":"Zolnik","year":"2010","journal-title":"Endocrinology."},{"key":"10.1016\/j.addr.2020.06.025_bb0380","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1001\/jama.1980.03300430028018","article-title":"Intravenous iron dextran in clinical medicine","volume":"243","author":"Hamstra","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2020.06.025_bb0385","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.2004.08.119","article-title":"Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial","volume":"22","author":"Auerbach","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2020.06.025_bb0390","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2007.15.4609","article-title":"Should intravenous iron be the standard of care in oncology?","volume":"26","author":"Auerbach","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"Supplement 4","key":"10.1016\/j.addr.2020.06.025_bb0395","article-title":"Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines","volume":"29","author":"Aapro","year":"2018","journal-title":"Ann. Oncol"},{"key":"10.1016\/j.addr.2020.06.025_bb0400","first-page":"657","article-title":"Should the ASCO\/ASH guidelines for the use of intravenous iron in cancer- and chemotherapy-induced anemia be updated?","volume":"12","author":"Gafter-Gvili","year":"2014","journal-title":"JNCCN"},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2020.06.025_bb0405","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2146\/ajhp110039","article-title":"Iron replacement therapy in cancer-related anemia","volume":"68","author":"Baribeault","year":"2011","journal-title":"Am. J. Health-Syst. Pharm"},{"key":"10.1016\/j.addr.2020.06.025_bb0410","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/s12885-016-2686-2","article-title":"Is there a role of intravenous iron for the treatment of anemia in cancer?","volume":"16","author":"Gemici","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.addr.2020.06.025_bb0415","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI35180","article-title":"The anticancer immune response: indispensable for therapeutic success?","volume":"118","author":"Zitvogel","year":"2008","journal-title":"J. Clin. Investigation"},{"key":"10.1016\/j.addr.2020.06.025_bb0420","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"14","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.addr.2020.06.025_bb0425","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fphar.2014.00152","article-title":"Iron at the interface of immunity and infection","volume":"5","author":"Nairz","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2020.06.025_bb0430","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1462-5822.2010.01529.x","article-title":"The struggle for iron \u2013 a metal at the host-pathogen interface","volume":"12","author":"Nairz","year":"2010","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.addr.2020.06.025_bb0435","series-title":"Human Vaccines & Immunotherapeutics","article-title":"Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant","author":"Neto","year":"2018"},{"key":"10.1016\/j.addr.2020.06.025_bb0440","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2217\/nnm.12.111","article-title":"Complex encounters: nanoparticles in whole blood and their uptake into different types of white blood cells","volume":"8","author":"Baumann","year":"2013","journal-title":"Nanomedicine-UK"},{"key":"10.1016\/j.addr.2020.06.025_bb0445","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nature08604","article-title":"Materials engineering for immunomodulation","volume":"462","author":"Hubbell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.06.025_bb0450","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nnano.2011.149","article-title":"A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy","volume":"6","author":"Cho","year":"2011","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2020.06.025_bb0455","doi-asserted-by":"crossref","first-page":"1706098","DOI":"10.1002\/adma.201706098","article-title":"A dual immunotherapy nanoparticle improves T-cell activation and cancer immunotherapy","volume":"30","author":"Mi","year":"2018","journal-title":"Adv. Mat."},{"key":"10.1016\/j.addr.2020.06.025_bb0460","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nnano.2017.113","article-title":"Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy","volume":"12","author":"Min","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2020.06.025_bb0465","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2020.06.025_bb0470","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nnano.2009.175","article-title":"Evaluation of nanoparticle immunotoxicity","volume":"4","author":"Dobrovolskaia","year":"2009","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2020.06.025_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2014.00051","article-title":"Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy","volume":"4","author":"Wood","year":"2014","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.addr.2020.06.025_bb0480","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.4049\/jimmunol.171.8.4352","article-title":"Selective depletion of nonspecific T cells during the early stages of immune responses to infection","volume":"171","author":"Jiang","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2020.06.025_bb0485","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/nl060860z","article-title":"The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications","volume":"6","author":"Vallhov","year":"2006","journal-title":"Nano Lett"},{"key":"10.1016\/j.addr.2020.06.025_bb0490","unstructured":"FDA, US Food and Drug Administration Report of the FDA Nanotechnology Task Force (FDA, 2007); available at: <http:\/\/tinyurl.com\/n6c2zl>."},{"key":"10.1016\/j.addr.2020.06.025_bb0495","first-page":"742","article-title":"Progress in nanomedicine: approved and investigational Nanodrugs","volume":"42","author":"Ventola","year":"2017","journal-title":"P & T"},{"key":"10.1016\/j.addr.2020.06.025_bb0500","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.addr.2018.09.012","article-title":"Animal models for analysis of immunological responses to nanomaterials: challenges and considerations","volume":"136","author":"Zamboni","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.06.025_bb0505","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/ijms18061249","article-title":"Emerging role of the spleen in the pharmacokinetics of monoclonal antibodies, nanoparticles and exosomes","volume":"18","author":"Cataldi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2020.06.025_bb0510","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine (London, England)"},{"key":"10.1016\/j.addr.2020.06.025_bb0515","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.4049\/jimmunol.0902214","article-title":"Curvature of synthetic and natural surfaces is an important target feature in classical pathway complement activation","volume":"184","author":"Pedersen","year":"2010","journal-title":"J. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.addr.2020.06.025_bb0520","first-page":"195","article-title":"Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge","volume":"9","author":"Kim","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2020.06.025_bb0525","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1172\/JCI66895","article-title":"Nanoparticle clearance is governed by Th1\/Th2 immunity and strain background","volume":"123","author":"Jones","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2020.06.025_bb0530","first-page":"216","article-title":"Hypersensitivity and nanoparticles: update and research trends","volume":"89","author":"Mocan","year":"2016","journal-title":"Clujul Med."},{"key":"10.1016\/j.addr.2020.06.025_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-30915-7","article-title":"Bare surface of gold nanoparticle induces inflammation through unfolding of plasma fibrinogen","volume":"8","author":"Kharazian","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2020.06.025_bb0540","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.2147\/IJN.S124661","article-title":"The metal nanoparticle-induced inflammatory response is regulated by SIRT1 through NF-\u03baB deacetylation in aseptic loosening","volume":"12","author":"Deng","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2020.06.025_bb0545","series-title":"Handbook of Immunological Properties of Engineered Nanomaterials: Volume 3: Engineered Nanomaterials and the Immune Cell Function","first-page":"139","article-title":"Immunosuppressive and anti-inflammatory properties of engineered nanomaterials","author":"Ilinskaya","year":"2016"},{"key":"10.1016\/j.addr.2020.06.025_bb0550","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1177\/1535370216650053","article-title":"Nanoparticles and direct immunosuppression","volume":"241","author":"Ngobili","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.addr.2020.06.025_bb0555","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/anie.201105187","article-title":"Polyvalent immunostimulatory nanoagents with self-assembled CpG oligonucleotide-conjugated gold nanoparticles","volume":"51","author":"Wei","year":"2012","journal-title":"Angew. Chem."},{"key":"10.1016\/j.addr.2020.06.025_bb0560","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/acs.bioconjchem.7b00793","article-title":"Complement activation by PEGylated gold nanoparticles","volume":"29","author":"Quach","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2020.06.025_bb0565","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.addr.2011.06.002","article-title":"Material properties in complement activation","volume":"63","author":"Moghimi","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.06.025_bb0570","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.etap.2010.05.004","article-title":"Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles","volume":"30","author":"Park","year":"2010","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.addr.2020.06.025_bb0575","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1016\/j.biomaterials.2013.06.048","article-title":"Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats","volume":"34","author":"De Jong","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.06.025_bb0580","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1183\/09031936.00168509","article-title":"Lung exposure to nanoparticles modulates an asthmatic response in a mouse model","volume":"37","author":"Hussain","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2020.06.025_bb0585","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1080\/01926230601094552","article-title":"Acute and subacute pulmonary toxicity of low dose of ultrafine colloidal silica particles in mice after intratracheal instillation","volume":"34","author":"Kaewamatawong","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.addr.2020.06.025_bb0590","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tox.2010.06.002","article-title":"Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice","volume":"275","author":"Park","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.addr.2020.06.025_bb0595","first-page":"1229","article-title":"A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB\/c mice","volume":"6","author":"Shen","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2020.06.025_bb0600","doi-asserted-by":"crossref","first-page":"13227","DOI":"10.1073\/pnas.1609397113","article-title":"In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis","volume":"113","author":"Kirschbaum","year":"2016","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.addr.2020.06.025_bb0605","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.4049\/jimmunol.1301433","article-title":"Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles","volume":"191","author":"Lo","year":"2013","journal-title":"J. Immunol"},{"key":"10.1016\/j.addr.2020.06.025_bb0610","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1021\/acsnano.6b08152","article-title":"Dual targeting nanoparticle stimulates the immune system to inhibit tumor growth","volume":"11","author":"Kosmides","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.06.025_bb0615","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ajim.22344","article-title":"Occupational handling of nickel nanoparticles: a case report","volume":"57","author":"Journeay","year":"2014","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.addr.2020.06.025_bb0620","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2486\/indhealth.2013-0100","article-title":"Sneezing and allergic dermatitis were increased in engineered nanomaterial handling workers","volume":"52","author":"Liao","year":"2014","journal-title":"Ind. Health"},{"key":"10.1016\/j.addr.2020.06.025_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02656730150201552","article-title":"Hyperthermia in oncology","volume":"17","author":"Falk","year":"2001","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0630","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02656736.2014.968640","article-title":"Local tumour hyperthermia as immunotherapy for metastatic cancer","volume":"30","author":"Toraya-Brown","year":"2014","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0635","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/02656736.2016.1157216","article-title":"Improving efficacy of hyperthermia in oncology by exploiting biological mechanisms","volume":"32","author":"van den Tempel","year":"2016","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0640","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ctrv.2015.05.009","article-title":"Local hyperthermia combined with radiotherapy and\u2212\/or chemotherapy: recent advances and promises for the future","volume":"41","author":"Datta","year":"2015","journal-title":"Cancer Treatment Rev."},{"key":"10.1016\/j.addr.2020.06.025_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02656739109004971","article-title":"Hyperthermia: an ancient science in India","volume":"7","author":"Singh","year":"1991","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0650","first-page":"509","article-title":"Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia","volume":"28","author":"Dewhirst","year":"2012","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0655","series-title":"Hyperthermia. Clinical Radiation Oncology","first-page":"385","author":"Dewhirst","year":"2011"},{"key":"10.1016\/j.addr.2020.06.025_bb0660","series-title":"Cancer Treatment \u2013 Conventional and Innovative Approaches","first-page":"257","article-title":"Ch. Hyperthermia: Cancer Treatment and Beyond","author":"Bettaieb","year":"2013"},{"key":"10.1016\/j.addr.2020.06.025_bb0665","first-page":"37","article-title":"Essential facts on the history of hyperthermia and their connections with electromedicine","volume":"87","author":"Gas","year":"2011","journal-title":"Przeglad Elektrotechniczny"},{"key":"10.1016\/j.addr.2020.06.025_bb0670","series-title":"Current Cancer Treatment \u2013 Novel Beyond Conventional Approaches","first-page":"455","article-title":"Ch. Hyperthermia: Cancer Treatment and Beyond","author":"Sardari","year":"2013"},{"key":"10.1016\/j.addr.2020.06.025_bb0675","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clon.2007.03.015","article-title":"Hyperthermia: a potent enhancer of radiotherapy","volume":"19","author":"Horsman","year":"2007","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.addr.2020.06.025_bb0680","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/02656736.2019.1665718","article-title":"Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity: a systematic review","volume":"36","author":"Bakker","year":"2019","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0685","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/cancers11010060","article-title":"Hyperthermia: the optimal treatment to overcome radiation resistant hypoxia","volume":"11","author":"Elming","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.addr.2020.06.025_bb0690","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/02656736.2011.616182","article-title":"Effector CD8+ T cell IFN-\u03b3 production and cytotoxicity are enhance by mild hyperthermia","volume":"28","author":"Mace","year":"2012","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0695","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/02656736.2018.1564155","article-title":"Quality assurance guidelines for interstitial hyperthermia","volume":"36","author":"Dob\u0161i\u010dek Trefn\u00e1","year":"2019","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-015-0462-0","article-title":"Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all","volume":"10","author":"Oei","year":"2015","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.addr.2020.06.025_bb0705","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/02656736.2015.1119317","article-title":"Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application","volume":"32","author":"Issels","year":"2016","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0710","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/02656736.2015.1110757","article-title":"Thermoradiotherapy planning: integration in routine clinical practice","volume":"32","author":"Crezee","year":"2015","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0715","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1158\/2326-6066.CIR-13-0118","article-title":"Temperature matters! And why it should matter to tumor immunologists","volume":"1","author":"Repasky","year":"2013","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.addr.2020.06.025_bb0720","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.it.2013.06.005","article-title":"Immunosurveillance as a regulator of tissue homeostatis","volume":"34","author":"Senovilla","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2020.06.025_bb0725","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/02656736.2012.677933","article-title":"Old and new facts about hyperthermia-induced modulations of the immune system","volume":"28","author":"Repasky","year":"2012","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0730","series-title":"Cancer Medicine","first-page":"623","article-title":"Hyperthermia","author":"Dewhirst","year":"2003"},{"key":"10.1016\/j.addr.2020.06.025_bb0735","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/02656736.2011.589234","article-title":"Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies","volume":"27","author":"Knippertz","year":"2012","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0740","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1189\/jlb.0506347","article-title":"Influence of heat stress on human monocyte-derived dendritic cell functions with immunotherapeutic potential for antitumor vaccines","volume":"81","author":"Hatzfeld-Charbonnier","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2020.06.025_bb0745","first-page":"528","article-title":"Thermal ablation versus conventional regional hyperthermia has greater anti-tumor activity against melanoma in mice by upregulating CD4+ cells and enhancing IL-2 secretion","volume":"28","author":"Zhang","year":"2012","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0750","doi-asserted-by":"crossref","first-page":"20477","DOI":"10.1073\/pnas.1006646107","article-title":"NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment","volume":"107","author":"Moon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2020.06.025_bb0755","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1172\/JCI44952","article-title":"IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells","volume":"121","author":"Fisher","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2020.06.025_bb0760","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/02656736.2019.1685686","article-title":"Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer","volume":"39","author":"Oei","year":"2019","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0765","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1128\/MCB.00475-13","article-title":"Hyperthermia stress activates heat shock protein expression via propyl isomerase 1 regulation with heat shock factor 1","volume":"33","author":"Wang","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.addr.2020.06.025_bb0770","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/intimm\/12.11.1539","article-title":"Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway","volume":"12","author":"Basu","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.addr.2020.06.025_bb0775","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.191.3.423","article-title":"Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells","volume":"191","author":"Sauter","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2020.06.025_bb0780","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/02656736.2011.589234","article-title":"Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies","volume":"27","author":"Knippertz","year":"2012","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0785","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/02656736.2012.677933","article-title":"Old and new facts about hyperthermia-induced modulations of the immune system","volume":"28","author":"Frey","year":"2012","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0790","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/02656736.2011.616182","article-title":"Effector CD8+ T-cell IFN-\u03b3 production and cytotoxicity are enhanced by mild hyperthermia","volume":"28","author":"Mace","year":"2012","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0795","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1189\/jlb.0506347","article-title":"Influence of heat stress on human monocyte-derived dendritic cell functions with immunotherapeutic potential for antitumor vaccines","volume":"81","author":"Hatzfeld-Charbonnier","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2020.06.025_bb0800","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1158\/0008-5472.CAN-12-0210","article-title":"Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies","volume":"72","author":"Verbrugge","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.addr.2020.06.025_bb0805","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4161\/cbt.8.15.9133","article-title":"Enhancing immune responses to tumor-associated antigens","volume":"8","author":"Higgins","year":"2009","journal-title":"Cancer Biol Ther."},{"key":"10.1016\/j.addr.2020.06.025_bb0810","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/annonc\/mds262","article-title":"Combination immunotherapy approaches","volume":"23","author":"Drake","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2020.06.025_bb0815","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.nano.2014.01.011","article-title":"Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors","volume":"10","author":"Toraya-Brown","year":"2014","journal-title":"Nanomedicine."},{"key":"10.1016\/j.addr.2020.06.025_bb0820","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2017.01.025","article-title":"To heat or not to heat: challenges with clinical translation of thermosensitive liposomes","volume":"249","author":"Dou","year":"2017","journal-title":"J. Controlled Rel."},{"key":"10.1016\/j.addr.2020.06.025_bb0825","unstructured":"ClinicalTrials.gov, Study of ThermoDox with Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) (OPTIMA). In: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02112656?term=optima+thermodox&rank=1"},{"key":"10.1016\/j.addr.2020.06.025_bb0830","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1158\/1078-0432.CCR-16-2433","article-title":"Phase III HEAT study adding lyso-thermosensitive liposomal doxorubicin to radiofrequency ablation in patients with unresectable hepatocellular carcinoma lesions","volume":"24","author":"Tak","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2020.06.025_bb0835","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00000658-195710000-00007","article-title":"Selective inductive heating of lymph nodes","volume":"146","author":"Gilchrist","year":"1957","journal-title":"Ann. Surg."},{"key":"10.1016\/j.addr.2020.06.025_bb0840","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/02656736.2013.857434","article-title":"Magnetic nanoparticle hyperthermia: a new frontier in biology and medicine?","volume":"29","author":"Ivkov","year":"2013","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0845","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/02656736.2013.836758","article-title":"Physics of heat generation using magnetic nanoparticles for hyperthermia","volume":"29","author":"Dennis","year":"2013","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0850","unstructured":"M.L. Etheridge, J.C. Bischof, A. Jordan. Magnetic nanoparticles for cancer therapy; Physics of Thermal Therapy: Fundamentals and Clinical Applications, E.G. Moros; Series in: Imaging in medical diagnosis and therapy (Series Ed. W.R. Hendee) CRC Press, Taylor&Francis Group, Boca Raton, FL USA (Chapter 17; pp 293\u2013318)."},{"key":"10.1016\/j.addr.2020.06.025_bb0855","unstructured":"Announcement on company site (https:\/\/www.magforce.com\/en\/home\/about_magforce\/#highlights)."},{"key":"10.1016\/j.addr.2020.06.025_bb0860","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11060-005-9059-z","article-title":"The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma","volume":"78","author":"Jordan","year":"2006","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.addr.2020.06.025_bb0865","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11060-006-9195-0","article-title":"Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme","volume":"81","author":"Maier-Hauff","year":"2007","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.addr.2020.06.025_bb0870","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-010-0389-0","article-title":"Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme","volume":"103","author":"Maier-Hauff","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.addr.2020.06.025_bb0875","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/02656730601106037","article-title":"Magnetic nanoparticles for interstitial thermotherapy \u2013 feasibility, tolerance, and achieved temperatures","volume":"22","author":"Wust","year":"2006","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0880","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.eururo.2006.11.023","article-title":"Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution","volume":"52","author":"Johannsen","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.addr.2020.06.025_bb0885","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/02656730601175479","article-title":"Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial","volume":"23","author":"Johannsen","year":"2007","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0890","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3109\/02656731003745740","article-title":"Magnetic nanoparticle hyperthermia for prostate cancer","volume":"26","author":"Johannsen","year":"2010","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0895","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/02656730500158360","article-title":"Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique","volume":"21","author":"Johannsen","year":"2005","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0900","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/02656736.2015.1005178","article-title":"Magnetic nanoparticle hyperthermia enhances radiation therapy: a study in mouse models of human prostate cancer","volume":"31","author":"Attaluri","year":"2015","journal-title":"Int. J. Hyperthermia"},{"key":"10.1016\/j.addr.2020.06.025_bb0905","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jmmm.2006.10.1151","article-title":"Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy","volume":"311","author":"Gruettner","year":"2007","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.addr.2020.06.025_bb0910","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/02656736.2013.835876","article-title":"Synthesis and functionalization of magnetic nanoparticles for hyperthermia applications","volume":"29","author":"Gr\u00fcttner","year":"2013","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0915","doi-asserted-by":"crossref","first-page":"395103","DOI":"10.1088\/0957-4484\/20\/39\/395103","article-title":"Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia","volume":"20","author":"Dennis","year":"2009","journal-title":"Nanotechnology"},{"key":"10.1016\/j.addr.2020.06.025_bb0920","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1002\/adfm.201500405","article-title":"Internal magnetic structure of nanoparticles dominates time-dependent relaxation processes in a magnetic field","volume":"25","author":"Dennis","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2020.06.025_bb0925","doi-asserted-by":"crossref","first-page":"215705","DOI":"10.1088\/1361-6528\/aab31d","article-title":"Correlation between physical structure and magnetic anisotropy of a magnetic nanoparticle colloid","volume":"29","author":"Dennis","year":"2018","journal-title":"Nanotechnology"},{"key":"10.1016\/j.addr.2020.06.025_bb0930","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/02656739609027678","article-title":"Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro","volume":"12","author":"Jordan","year":"1996","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0935","doi-asserted-by":"crossref","first-page":"124904","DOI":"10.1063\/1.3597820","article-title":"Magnetic nanoparticle heating efficiency reveals magneto-structural differences when characterized with a wide ranging and high amplitude alternating magnetic field","volume":"109","author":"Bordelon","year":"2011","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.addr.2020.06.025_bb0940","doi-asserted-by":"crossref","DOI":"10.1063\/1.3488881","article-title":"Influence of dipolar interactions on hyperthermia properties of ferromagnetic particles","volume":"108","author":"Serantes","year":"2010","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.addr.2020.06.025_bb0945","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1002\/adfm.201200307","article-title":"Adjustable hyperthermia response of self-assembled ferromagnetic Fe-MgO Core\u2013Shell nanoparticles by tuning dipole\u2013dipole interactions","volume":"22","author":"Mart\u00ednez-Boubeta","year":"2012","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2020.06.025_bb0950","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1038\/srep02887","article-title":"Effect of magnetic dipolar interactions on nanoparticle heating efficiency: implications for cancer hyperthermia","volume":"3","author":"Branquinho","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2020.06.025_bb0955","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1038\/s41598-017-07088-w","article-title":"Experimental estimation and analysis of variance of the measured loss power of magnetic nanoparticles","volume":"7","author":"Soetaert","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2020.06.025_bb0960","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/02656736.2013.826825","article-title":"Accuracy of available methods for quantifying the heat power generation of nanoparticles for magnetic hyperthermia","volume":"29","author":"Andreu","year":"2013","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0965","doi-asserted-by":"crossref","first-page":"455005","DOI":"10.1088\/1361-6463\/aa89de","article-title":"Uncertainties in the estimation of specific absorption rate during radiofrequency alternating magnetic field induced non-adiabatic heating of ferrofluids","volume":"50","author":"Lahiri","year":"2017","journal-title":"J. Phys. D. Appl. Phys."},{"key":"10.1016\/j.addr.2020.06.025_bb0970","doi-asserted-by":"crossref","first-page":"255001","DOI":"10.1088\/1361-6463\/ab140c","article-title":"A standardization protocol for accurate evaluation of specific loss power in magnetic hyperthermia","volume":"52","author":"Makridis","year":"2019","journal-title":"J. Phys. D. Appl. Phys."},{"key":"10.1016\/j.addr.2020.06.025_bb0975","doi-asserted-by":"crossref","DOI":"10.1063\/1.2891084","article-title":"Accurate measurement of the specific absorption rate using a suitable adiabatic magnetothermal setup","volume":"92","author":"Natividad","year":"2008","journal-title":"Appl. Phys. Lett."},{"key":"10.1016\/j.addr.2020.06.025_bb0980","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.applthermaleng.2016.02.063","article-title":"Uses and limitation of different thermometers for measuring heating efficiency of magnetic fluids","volume":"100","author":"Skumiel","year":"2016","journal-title":"Appl. Therm. Eng."},{"key":"10.1016\/j.addr.2020.06.025_bb0985","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3109\/02656736.2013.826824","article-title":"Relationship between physico-chemical properties of magnetic fluids and their heating capacity","volume":"29","author":"Salas","year":"2013","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0990","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3109\/02656736.2013.822993","article-title":"Magnetic nanoparticle heating and heat transfer on a microscale: basic principles, realities and physical limitations for tumour therapy","volume":"29","author":"Dutz","year":"2013","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb0995","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1021\/acsnano.7b01762","article-title":"Size-dependent heating of magnetic Iron oxide nanoparticles","volume":"11","author":"Tong","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.06.025_bb1000","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12938-017-0327-x","article-title":"Physical mechanism and modeling of heat generation and transfer in magnetic fluid hyperthermia through N\u00e9elian and Brownian relaxation: a review","volume":"16","author":"Suriyanto","year":"2017","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.addr.2020.06.025_bb1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1063\/1.3551582","article-title":"Simple models for dynamic hysteresis loop calculations of magnetic singl-domain nanoparticles: application to magnetic hyperthermia optimization","volume":"109","author":"Carrey","year":"2011","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.addr.2020.06.025_bb1010","doi-asserted-by":"crossref","first-page":"502003","DOI":"10.1088\/1361-6528\/ab4241","article-title":"Magnetic nanoparticles in nanomedicine: a review of recent advances","volume":"30","author":"Wu","year":"2019","journal-title":"Nanotechnology"},{"key":"10.1016\/j.addr.2020.06.025_bb1015","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1038\/srep09090","article-title":"Unified model of hyperthermia via hysteresis heating in systems of interacting magnetic nanoparticles","volume":"5","author":"Ruta","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2020.06.025_bb1020","doi-asserted-by":"crossref","first-page":"452001","DOI":"10.1088\/0957-4484\/25\/45\/452001","article-title":"Magnetic particle hyperthermia \u2013 a promising tumour therapy?","volume":"25","author":"Dutz","year":"2014","journal-title":"Nanotechnology"},{"key":"10.1016\/j.addr.2020.06.025_bb1025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jmmm.2018.04.032","article-title":"Biomedical nanoparticle carriers with combined thermal and magnetic response: current preclinical investigations","volume":"461","author":"Tebaldi","year":"2018","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.addr.2020.06.025_bb1030","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevB.85.045435","article-title":"Role of dipole-dipole interactions for hyperthermia heating of magnetic nanoparticle ensembles","volume":"85","author":"Haase","year":"2012","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.addr.2020.06.025_bb1035","doi-asserted-by":"crossref","first-page":"123909","DOI":"10.1063\/1.3445879","article-title":"Low frequency hysteresis loops of superparamagnetic nanoparticles with uniaxial anisotropy","volume":"107","author":"Usov","year":"2010","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.addr.2020.06.025_bb1040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jmmm.2018.09.041","article-title":"Predicting size-dependent heating efficiency of magnetic nanoparticles from experiment and stochastic N\u00e9el-Brown Lengevin simulation","volume":"471","author":"Engelmann","year":"2019","journal-title":"J. Magn. Magn. Mat."},{"key":"10.1016\/j.addr.2020.06.025_bb1045","series-title":"Biological and Medical Aspects of Electromagnetic Fields","author":"Barnes","year":"2006"},{"key":"10.1016\/j.addr.2020.06.025_bb1050","series-title":"Bioengineering and Biophysical Aspects of Electromagnetic Fields","author":"Greenebaum","year":"2006"},{"key":"10.1016\/j.addr.2020.06.025_bb1055","series-title":"Hyperthermia in Cancer Treatment: A Primer: A Primer: Landes Bioscience","author":"Baronzio","year":"2008"},{"key":"10.1016\/j.addr.2020.06.025_bb1060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF02345121","article-title":"Numerical simulation of thermal deposition with induction heating used for oncological hyperthermia treatment","volume":"43","author":"Dughiero","year":"2006","journal-title":"Med. Biol. Eng. Comput."},{"key":"10.1016\/j.addr.2020.06.025_bb1065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1109\/TBME.1984.325372","article-title":"Usable frequencies in hyperthermia with thermal seeds","volume":"31","author":"Atkinson","year":"1984","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.addr.2020.06.025_bb1070","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1109\/20.101117","article-title":"Energy considerations in the magnetic (eddy-current) stimulation of tissues","volume":"27","author":"Nyenhuis","year":"1991","journal-title":"IEEE Trans. Magn."},{"key":"10.1016\/j.addr.2020.06.025_bb1075","series-title":"Bioengineering and Biophysical Aspects of Electromagnetic Fields","first-page":"239","article-title":"Computational methods for predicting field intensity and temperature change","author":"Lin","year":"2007"},{"key":"10.1016\/j.addr.2020.06.025_bb1080","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1109\/TBME.2003.813538","article-title":"On the induced electric field gradients in the human body for magnetic stimulation by gradient coils in MRI","volume":"50","author":"Liu","year":"2003","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.addr.2020.06.025_bb1085","series-title":"Biological and Medical Aspects of Electromagnetic Fields","first-page":"215","article-title":"Thermoregulation in the presence of radio frequency fields","author":"Black","year":"2006"},{"key":"10.1016\/j.addr.2020.06.025_bb1090","series-title":"Biological and Medical Aspects of Electromagnetic Fields","first-page":"xiii","article-title":"Introduction","author":"Polk","year":"2006"},{"key":"10.1016\/j.addr.2020.06.025_bb1095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02656736.2019.1704448","article-title":"Design and construction of a Maxwell-type inductor coil for magnetic nanoparticle hyperthermia","volume":"37","author":"Attaluri","year":"2020","journal-title":"Int. J. Hyperthermia"},{"key":"10.1016\/j.addr.2020.06.025_bb1100","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3109\/02656736.2013.832815","article-title":"In vivo applications of magnetic nanoparticle hyperthermia","volume":"29","author":"Hilger","year":"2013","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb1105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10439-012-0633-1","article-title":"Optimizing magnetic nanoparticle based thermal therapies within the physical limits of heating","volume":"41","author":"Etheridge","year":"2013","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.addr.2020.06.025_bb1110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/02656736.2019.1628313","article-title":"Evaluation of magnetic nanoparticles for magnetic fluid hyperthermia","volume":"36","author":"Lanier","year":"2019","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb1115","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1080\/02656736.2018.1430867","article-title":"Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy\u2019s history, efficacy, and application in humans","volume":"34","author":"Mahmoudi","year":"2018","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb1120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/02656730802203377","article-title":"An in vivo experimental study of temperature elevations in animal tissue during magnetic nanoparticle hyperthermia","volume":"24","author":"Salloum","year":"2008","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb1125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.mechrescom.2011.05.012","article-title":"Diffusion of magnetic nanoparticles in a multi-site injection process within a biological tissue during magnetic fluid hyperthermia using lattice Boltzmann method","volume":"38","author":"Golneshan","year":"2011","journal-title":"Mech. Res. Commun."},{"key":"10.1016\/j.addr.2020.06.025_bb1130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/02656736.2018.1538538","article-title":"Temperature-controlled power modulation compensates for heterogeneous nanoparticle distributions: a computational optimization analysis for magnetic hyperthermia","volume":"36","author":"Kandala","year":"2019","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb1135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0306-9877(79)90063-X","article-title":"Intracellular hyperthermia a biophysical approach to cancer treatment via intracellular termperature and biophysical alterations","volume":"5","author":"Gordon","year":"1979","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.addr.2020.06.025_bb1140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/02656730110116713","article-title":"Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense?","volume":"18","author":"Rabin","year":"2002","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.06.025_bb1145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2217\/nnm.12.98","article-title":"The effect of cell cluster size on intracellular nanoparticle-mediated hyperthermia: is it possible to treat microscopic tumors?","volume":"8","author":"Hedayati","year":"2013","journal-title":"Nanomedicine, UK"},{"key":"10.1016\/j.addr.2020.06.025_bb1150","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1021\/nn201822b","article-title":"EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise","volume":"5","author":"Creixell","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.06.025_bb1155","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2217\/nnm.13.207","article-title":"Monitoring nanoparticle mediated cellular hyperthermia with a high sensitivity biosensor","volume":"9","author":"Mukherjee","year":"2014","journal-title":"Nanomedicine-London"},{"key":"10.1016\/j.addr.2020.06.025_bb1160","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2020.06.025_bb1165","first-page":"12","article-title":"Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation","volume":"27","author":"Hodge","year":"2012","journal-title":"Cancer Bioth. Radiopharm."},{"key":"10.1016\/j.addr.2020.06.025_bb1170","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2020.06.025_bb1175","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/pros.20794","article-title":"Radiotherapy augments the immune response to prostate cancer in a time-dependent manner","volume":"68","author":"Harris","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.addr.2020.06.025_bb1180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028217","article-title":"\u03b3-radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo","volume":"6","author":"Sharma","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2020.06.025_bb1185","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1021\/acs.nanolett.9b00579","article-title":"Iron nanoparticles for low-power local magnetic hyperthermia in combination with immune checkpoint blockade for systemic antitumor therapy","volume":"19","author":"Chao","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2020.06.025_bb1190","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/acsnano.9b08550","article-title":"Combined magnetic hyperthermia and immune therapy for primary and metastatic tumor treatments","volume":"14","author":"Pan","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.06.025_bb1195","doi-asserted-by":"crossref","first-page":"1901690","DOI":"10.1002\/advs.201901690","article-title":"Janus Nanobullets combine photodynamic therapy and magnetic hyperthermia to potentiate synergetic anti-metastatic immunotherapy","volume":"6","author":"Wang","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.addr.2020.06.025_bb1200","article-title":"Hypo-fractionated Radiation, Magnetic Nanoparticle Hyperthermia and a Viral Immunotherapy Treatment of Spontaneous Canine Cancer","volume":"10066","author":"Hoopes","year":"2017","journal-title":"Proc SPIE Int Soc Opt Eng"},{"key":"10.1016\/j.addr.2020.06.025_bb1205","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.cgt.7700648","article-title":"Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles","volume":"10","author":"Ito","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.addr.2020.06.025_bb1210","article-title":"Effect of intra-tumoral magnetic nanoparticle hyperthermia and viral nanoparticle immunogenicity on primary and metastatic cancer","volume":"10066G","author":"Hoopes","year":"2017","journal-title":"Proc. SPIE Int. Soc. Opt. Eng."},{"key":"10.1016\/j.addr.2020.06.025_bb1215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00008390-200304000-00004","article-title":"Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes","volume":"13","author":"Suzuki","year":"2003","journal-title":"Melanoma Res."},{"key":"10.1016\/j.addr.2020.06.025_bb1220","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2020.06.025_bb1225","series-title":"Magnetism and Magnetic Materials","author":"Coey","year":"2010"},{"key":"10.1016\/j.addr.2020.06.025_bb1230","series-title":"Advances in Chemical Physics","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/9780470141571.ch4","article-title":"Magnetic relaxation in fine-particle systems","author":"Dormann","year":"1997"},{"key":"10.1016\/j.addr.2020.06.025_bb1235","article-title":"Giant-spin nonlinear response theory of magnetic nanoparticle hyperthermia: a field dependence study","volume":"111","author":"Carriao","year":"2012","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.addr.2020.06.025_bb1240","first-page":"99","article-title":"Th\u00e9orie du trainage magn\u00e9tique des ferromagn\u00e9tiques en grains fins avec applications aux terres cuites","volume":"5","author":"N\u00e9el","year":"1949","journal-title":"Ann G\u00e9ophys"},{"key":"10.1016\/j.addr.2020.06.025_bb1245","first-page":"664","article-title":"Influence of thermal fluctuations on the magnetization of ferromagnetic small particles","volume":"228","author":"N\u00e9el","year":"1949","journal-title":"C.R. Acad. Sci"},{"key":"10.1016\/j.addr.2020.06.025_bb1250","doi-asserted-by":"crossref","first-page":"121301","DOI":"10.1063\/1.4754272","article-title":"Thermal fluctuations of magnetic nanoparticles: fifty years after Brown","volume":"112","author":"Coffey","year":"2012","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.addr.2020.06.025_bb1255","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mattod.2019.06.003","article-title":"Magnetic iron oxide nanoparticles for disease detection and therapy","volume":"31","author":"Tong","year":"2019","journal-title":"Mater. Today"},{"key":"10.1016\/j.addr.2020.06.025_bb1260","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/srep01652","article-title":"Learning from nature to improve the heat generation of Iron-oxide nanoparticles for magnetic hyperthermia applications","volume":"3","author":"Martinez-Boubeta","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2020.06.025_bb1265","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1021\/jp410717m","article-title":"Multiplying magnetic hyperthermia response by nanoparticle assembling","volume":"118","author":"Serantes","year":"2014","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.addr.2020.06.025_bb1270","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0304-8853(02)00706-0","article-title":"Heating magnetic fluid with alternating magnetic field","volume":"252","author":"Rosensweig","year":"2002","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.addr.2020.06.025_bb1275","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1016\/j.biomaterials.2014.04.036","article-title":"Magnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs","volume":"35","author":"di Corato","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.06.025_bb1280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/nn503888j","article-title":"In Situ measurement of magnetization relaxation of internalized nanoparticles in live cells","volume":"9","author":"Soukup","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.06.025_bb1285","doi-asserted-by":"crossref","first-page":"21018","DOI":"10.1021\/acs.jpcc.8b04071","article-title":"Magnetization dynamics and energy dissipation of interacting magnetic nanoparticles in alternating magnetic fields with and without a static Bias field","volume":"122","author":"Zhao","year":"2018","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.addr.2020.06.025_bb1290","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00396-019-04546-x","article-title":"Influence of the cluster formation in a magnetic particle suspension on heat production effect in an alternating magnetic field","volume":"297","author":"Suzuki","year":"2019","journal-title":"Colloid Polymer Sci."},{"key":"10.1016\/j.addr.2020.06.025_bb1295","doi-asserted-by":"crossref","first-page":"38382","DOI":"10.1038\/srep38382","article-title":"In-situ particles reorientation during magnetic hyperthermia application: shape matters twice","volume":"6","author":"Simeonidis","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2020.06.025_bb1300","doi-asserted-by":"crossref","first-page":"15698","DOI":"10.1021\/acs.jpcc.5b02555","article-title":"A single picture explains diversity of hyperthermia response of magnetic nanoparticles","volume":"119","author":"Conde-Leboran","year":"2015","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.addr.2020.06.025_bb1305","doi-asserted-by":"crossref","first-page":"14527","DOI":"10.1039\/C7CP01442B","article-title":"Towards improved magnetic fluid hyperthermia: major-loops to diminish variations in local heating","volume":"19","author":"Munoz-Menendez","year":"2017","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.addr.2020.06.025_bb1310","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jmmm.2014.10.022","article-title":"Orientation of the magnetization easy axes of interacting nanoparticles: influence on the hyperthermia properties","volume":"380","author":"Conde-Leboran","year":"2015","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.addr.2020.06.025_bb1315","doi-asserted-by":"crossref","first-page":"30445","DOI":"10.1039\/C8CP02768D","article-title":"Anisotropic magnetic nanoparticles for biomedicine: bridging frequency separated AC-field controlled domains of actuation","volume":"20","author":"Serantes","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.addr.2020.06.025_bb1320","unstructured":"R. Ivkov, Magnetic nanoscale particle compositions, and therapeutic methods related thereto. US Patent 7,731,648."},{"key":"10.1016\/j.addr.2020.06.025_bb1325","doi-asserted-by":"crossref","first-page":"07A319","DOI":"10.1063\/1.2837647","article-title":"The influence of collective behavior on the magnetic and heating properties of iron oxide nanoparticles","volume":"103","author":"Dennis","year":"2008","journal-title":"J. Appl. Phys"},{"key":"10.1016\/j.addr.2020.06.025_bb1330","series-title":"Process for making iron oxide nanoparticle preparations for cancer hyperthermia, US Patent 10,406,228","author":"Ivkov","year":"2019"},{"key":"10.1016\/j.addr.2020.06.025_bb1335","doi-asserted-by":"crossref","first-page":"1700094","DOI":"10.1002\/ppsc.201700094","article-title":"Colloidal flower-shaped iron oxide nanoparticles: synthesis strategies and coatings","volume":"34","author":"Gavil\u00e1n","year":"2017","journal-title":"Part. Part. Syst. Charact."},{"key":"10.1016\/j.addr.2020.06.025_bb1340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2019.07.002","article-title":"Integrating nanomedicine into clinical radiotherapy regimens","volume":"144","author":"DuRoss","year":"2019","journal-title":"Adv. Drug. Del. Rev."},{"key":"10.1016\/j.addr.2020.06.025_bb1345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2018.01.005","article-title":"Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics","volume":"141","author":"Hong","year":"2019","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2020.06.025_bb1350","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2020.06.025_bb1355","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nantod.2019.02.005","article-title":"Clinical cancer nanomedicine","volume":"25","author":"Wolfram","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2020.06.025_bb1360","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd.2017.34","article-title":"Lessons from immuno-oncology: a new era for cancer nanomedicine?","volume":"16","author":"Jian","year":"2017","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.addr.2020.06.025_bb1365","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41565-019-0597-5","article-title":"The two directions of cancer nanomedicine","volume":"14","author":"Editorial","year":"2019","journal-title":"Nat. Nanotechnol"},{"key":"10.1016\/j.addr.2020.06.025_bb1370","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/nano9020191","article-title":"Clinical trials of thermosensitive nanomaterials: an overview","volume":"9","author":"Nardecchia","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.addr.2020.06.025_bb1375","series-title":"Principles of Cancer Genetics","author":"Bunz","year":"2016"},{"key":"10.1016\/j.addr.2020.06.025_bb1380","doi-asserted-by":"crossref","unstructured":"C. Tomasetti , B. Bogelstein, Variatino in cancer risk among tissuescn be explained by the number of stem cel divisions. Science 347 (215)(78\u201381.","DOI":"10.1126\/science.1260825"},{"key":"10.1016\/j.addr.2020.06.025_bb1385","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2019.06.048","article-title":"Influence of the gut microbiome, diet, and environment on risk of colorectal cancer","volume":"158","author":"Song","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2020.06.025_bb1390","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","article-title":"Gut microbiome in HCC \u2013 mechanisms, diagnosis, and therapy","volume":"72","author":"Schwabe","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.addr.2020.06.025_bb1395","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-pharmtox-010919-023612","article-title":"The role of the microbiome in drug response","volume":"60","author":"Pryor","year":"2020","journal-title":"Ann. Rev. Pharmacol. Toxicol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X20300715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X20300715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:56:53Z","timestamp":1759208213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X20300715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":279,"alternative-id":["S0169409X20300715"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2020.06.025","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2020.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}